Feb 2, 2021   SOURCE: PR NewsWire

Global Dry Eye Disease (DED) Market Insights & Forecast 2020-2024: A US$4.28 Billion Market by 2024

DUBLIN, Feb. 2, 2021 /PRNewswire/ -- The "Global Dry Eye Disease (DED) Market (by Type, Product, Treatment, Distribution Channel & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The global dry eye disease market is predicted to reach US$4.28 billion in 2024, witnessing growth at a CAGR of 5.23%, over the period 2020-2024. The factors such as increasing geriatric population, growing burden of diabetes, rising healthcare expenditure, surging prevalence of arthritis and upswing in air pollution are expected to drive the market. A few notable trends include the emerging number of contact lens users, surge in laser eye surgeries, rising screen time and technological advancements and promising pipeline products. However, the market would be challenged by dearth of skilled professionals, increasing popularity of self-medication by patients and stringent regulations.

The global dry eye disease market has been segmented on the basis of type, product, treatment and distribution channel. On the basis of type, the global dry eye disease market can be bifurcated into aqueous & evaporative dry eye disease, evaporative dry eye disease and aqueous dry eye disease. According to products, the global market can be categorized into Restasis, Xiidra, Systane, Refresh and other products. Whereas, depending on the treatment, the global market can be split into anti-inflammatory drugs, artificial tears, punctual plug and other treatments. The global dry eye disease is segmented into retail pharmacies, hospital pharmacies, online pharmacies and others.

The fastest growing regional market is North America due to the rising burden of chronic diseases such as diabetes and rheumatoid arthritis in the region, increasing healthcare expenditure, presence of a well-developed healthcare sector, growing adoption of prescription dry eye disease drugs in the U.S. and increasing number of approvals for new drugs and devices from the FDA.

Scope of the report:

    --  The report provides a comprehensive analysis of the global dry eye
        disease market segmented on the basis of type, product, treatment,
        distribution channel & region.
    --  The major regional and country markets (North America, Europe, Asia
        Pacific and Rest of the World) have been analyzed.
    --  The market dynamics such as growth drivers, market trends and challenges
        are analyzed in-depth.
    --  The competitive landscape of the market, along with the company profiles
        of leading players (Novartis International AG (Alcon Inc.), AbbVie Inc.
        (Allergan PLC), Otsuka Holdings Co., Ltd., Bausch Health Companies Inc.,
        Santen Pharmaceutical Co., Ltd., and Marinomed Biotech AG) are also
        presented in detail.

Key Topics Covered:

1. Market Overview
1.1 Introduction
1.2 Classification of Dry Eye Disease
1.3 Types of Dry Eye Disease
1.4 Triggers of Dry Eye Disease
1.5 Symptoms of Dry Eye Disease
1.6 Diagnosis of Dry Eyes Disease
1.7 Treatment and Medication Options for Dry Eye Disease

2. Impact of COVID-19
2.1 Decline in Industrial Production
2.2 Loss of Patient Volume
2.3 Impact on Healthcare Sector

3. Global Market Analysis
3.1 Global Dry Eye Disease Market by Value
3.2 Global Dry Eye Disease Market Forecast by Value
3.3 Global Dry Eye Disease Market by Type
3.4 Global Dry Eye Disease Market by Product
3.5 Global Dry Eye Disease Market by Treatment
3.6 Global Dry Eye Disease Market by Distribution Channel
3.7 Global Dry Eye Disease Market by Region

4. Regional Market Analysis
4.1 North America
4.2 Europe
4.3 Asia Pacific
4.4 RoW

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Geriatric Population
5.1.2 Growing Burden of Diabetes
5.1.3 Rising Healthcare Expenditure
5.1.4 Surging Prevalence of Arthritis
5.1.5 Expanding Urbanization
5.1.6 Upswing in Air Pollution
5.2 Key Trends & Developments
5.2.1 Emerging Number of Contact Lens Users
5.2.2 Surge in Laser Eye Surgeries
5.2.3 Rising Screen Time
5.2.4 Technological Advancements and Promising Pipeline Products
5.3 Challenges
5.3.1 Dearth of Skilled Ophthalmologists
5.3.2 Increasing Popularity of Self-Medication by Patients
5.3.3 Stringent Regulations

6. Competitive Landscape
6.1 Global Market
6.1.1 Revenue Comparison of Key Players
6.1.2 Market Capitalization Comparison of Key Players
6.1.3 R&D Comparison of Key Players

7. Company Profiles

    --  AbbVie Inc. (Allergan PLC)
    --  Bausch Health Companies Inc.
    --  Marinomed Biotech AG
    --  Novartis International AG (Alcon Inc.)
    --  Otsuka Holdings Co., Ltd.
    --  Santen Pharmaceutical Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/cj7v9y

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-dry-eye-disease-ded-market-insights--forecast-2020-2024-a-us4-28-billion-market-by-2024--301219973.html

SOURCE Research and Markets